info@aurevixpeptides.com
EspañolRead references
AUREVIX · REFERENCE LIBRARY

Compound combinations

Explore molecular identities and constituents associated with this field of study.

Explore 15 references →
AUREVIXAUREVIX

Compound reference

AUREVIX · REFERENCE LIBRARY

Explore the references.

Explore the reference for each compound.

Illustrative vial: KLOWKLOW
Compound reference

KLOW

This named combination contains BPC-157, GHK-CU, TB-500, KPV. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

GHK-Cu + BPC-157 + TB-500 + KPV
Read reference
Illustrative vial: WOLVERINEWOLVERINE
Compound reference

WOLVERINE

This named combination contains BPC-157, TB500. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

BPC-157 + TB-500
Read reference

More in this category.

Illustrative vial: Cagrilintide + SemaglutideCagrilintide + Semaglutide
Compound reference

Cagrilintide + Semaglutide

This named combination contains Cagrilintide, Semaglutide. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: CJC-1295 + Ipamorelin BlendCJC-1295 + Ipamorelin Blend
Compound reference

CJC-1295 + Ipamorelin Blend

This named combination contains CJC-1295 Without DAC, Ipamorelin. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Glow BlendGlow Blend
Compound reference

Glow Blend

This named combination contains BPC-157, GHK-CU, TB-500. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Metabolic BlendMetabolic Blend
Compound reference

Metabolic Blend

This named combination contains NAD+, MOTS-c, 5-amino-1MQ. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Selank + SemaxSelank + Semax
Compound reference

Selank (5 mg) + Semax (5mg)

This named combination contains Selank, Semax. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Semaglutide + BPC-157Semaglutide + BPC-157
Compound reference

Semaglutide (15mg) + BPC-157 (15mg)

This named combination contains Semaglutide, BPC-157. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Semaglutide + BPC-157Semaglutide + BPC-157
Compound reference

Semaglutide (30mg) + BPC-157 (30mg)

This named combination contains Semaglutide, BPC-157. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Semaglutide + BPC-157Semaglutide + BPC-157
Compound reference

Semaglutide (5mg) + BPC-157 (5mg)

This named combination contains Semaglutide, BPC-157. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Tesamorelin + IpamorelinTesamorelin + Ipamorelin
Compound reference

Tesamorelin (10mg) + Ipamorelin (5mg)

This named combination contains Tesamorelin, Ipamorelin. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Tesamorelin + Ipamorelin BlendTesamorelin + Ipamorelin Blend
Compound reference

Tesamorelin + Ipamorelin Blend

This named combination contains Tesamorelin, Ipamorelin. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Tirzepatide + BPC-157Tirzepatide + BPC-157
Compound reference

Tirzepatide (15 mg) + BPC-157 (15mg)

This named combination contains Tirzepatide, BPC-157. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Tirzepatide + BPC-157Tirzepatide + BPC-157
Compound reference

Tirzepatide (30 mg) + BPC-157 (30 mg)

This named combination contains Tirzepatide, BPC-157. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Illustrative vial: Tirzepatide + BPC-157Tirzepatide + BPC-157
Compound reference

Tirzepatide (50 mg) + BPC-157 (50 mg)

This named combination contains Tirzepatide, BPC-157. Each constituent has a distinct molecular identity; the name of a blend does not establish a combined biological effect.

Read reference
Explore all products →